The following forms are currently being revised / developed. Check back for new forms, and updates to the anticipated release dates.

Forms Anticipated Release Date Notes
Recipient Contact Information (2820) Summer 2019
Inotuzumab Ozogamicin (2541) Summer 2019
BMT CTN 1702 Adverse Event Form (2535) Summer 2019 new study specific form
BMT CTN 1702 Off Study Form (2536) Summer 2019 new study specific form
BMT CTN 1702 Protocol Deviation / Violation Form (2537) Summer 2019 new study specific form
Pre-TED (2400) Fall 2019 Currently being reviewed / revised.
Disease Classification (2402) Fall 2019 Currently being reviewed / revised.
Baseline (2000) Fall 2019 Currently being reviewed / revised.
HCT Product and Infusion (2006) Fall 2019 Currently being reviewed / revised.
Confirmation of HLA typing form (2005) Fall 2019 Currently being reviewed / revised.
Infectious disease markers (2004) Fall 2019 Currently being reviewed / revised.
Post-TED (2450) Fall 2019 Currently being reviewed / revised.
Multiple Myeloma / PCD Pre-Infusion Form (2016) Fall 2019 underwent complete revision
Multiple Myeloma / PCD Post-Infusion Form (2116) Fall 2019 underwent complete revision

For more information about the forms, or revision schedule, email cibmtrformfeedback@nmdp.org.

Last modified: 2019/07/03

Feedback

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.

Post your comment on this topic.

Please do not use this for support questions.
For customer support, please contact us here.

Post Comment